Scandinavian Biopharma expands its Nordic vaccine business with the oral typhoid vaccine Vivotif®

Scandinavian Biopharma has entered into a Nordic distribution agreement with Emergent Travel Health for the oral typhoid vaccine Vivotif®. Typhoid fever is a severe and potentially life-threatening infection caused by the Salmonella bacteria. The Scandinavian Biopharma team is very experienced in marketing and sales of vaccines. Since 1st of January 2020 Scandinavian Biopharma is the […]

Christine Källén joins Scandinavian Biopharma as our new VP Quality Assurance

Scandinavian Biopharma has in November appointed Christine Källén as VP Quality Assurance and she will supersede Annette Elmqvist, who is retiring at the end of the year. Christine’s career spans over more than 20 years in quality assurance. Most recently Christine worked at the Swedish Nuclear Fuel and Waste Management Company, SKB, where she was […]

Scandinavian Biopharma reports successful results of the oral, inactivated ETEC vaccine candidate ETVAX® against enterotoxigenic E. coli diarrhoea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh

The successful results of the Phase I/II study in Dhaka, Bangladesh, are now published in The Lancet Infectious Diseases. All predefined primary endpoints for the study were achieved and exceeded, showing that the vaccine candidate was safe and broadly immunogenic, stimulating immune responses to all key vaccine components. Only a few mild to moderate adverse […]

The successful immunogenicity and safety results of ETVAX® are presented at Vaccines for Enteric Diseases (VED) Oct 16-18 in Lausanne, Switzerland

Lausanne, Switzerland, Wednesday Oct 16 As a world leading company within diarrhoeal vaccine development, Scandinavian Biopharma is regularly invited to participate in global conferences that bring together renowned researchers and decision makers from the pharmaceutical industry, international authorities and global health organisations. Scandinavian Biopharma’s vaccine ETVAX® is rated as the most advanced vaccine in the […]

Scandinavian Biopharma awarded and qualified “Gazelle Company” by Dagens Industri

We are excited to share that we have been awarded the honourable title Gazelle company by Dagens Industri, DI. This means that we belong to the fastest growing companies in Sweden that are financially profitable with strong financial position. DI Gasell is a prize that is awarded by the financial newspaper Dagens Industri to Sweden’s […]



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.